nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—migraine—Prednisone—hematologic cancer	0.38	1	CpDpCtD
Antipyrine—PTGS2—Lenalidomide—hematologic cancer	0.0267	0.0485	CbGbCtD
Antipyrine—CYP2C18—Ifosfamide—hematologic cancer	0.0255	0.0464	CbGbCtD
Antipyrine—CYP2A6—Methoxsalen—hematologic cancer	0.017	0.0309	CbGbCtD
Antipyrine—CYP1A2—Anagrelide—hematologic cancer	0.0145	0.0264	CbGbCtD
Antipyrine—PTGS2—Thalidomide—hematologic cancer	0.0143	0.0259	CbGbCtD
Antipyrine—CYP2B6—Thiotepa—hematologic cancer	0.0142	0.0259	CbGbCtD
Antipyrine—PTGS1—Bortezomib—hematologic cancer	0.0138	0.0251	CbGbCtD
Antipyrine—CYP2A6—Ifosfamide—hematologic cancer	0.0124	0.0225	CbGbCtD
Antipyrine—PTGS1—Thalidomide—hematologic cancer	0.012	0.0219	CbGbCtD
Antipyrine—PTGS1—Ifosfamide—hematologic cancer	0.0106	0.0193	CbGbCtD
Antipyrine—PTGS1—Imatinib—hematologic cancer	0.0101	0.0184	CbGbCtD
Antipyrine—PTGS2—Triamcinolone—hematologic cancer	0.00988	0.018	CbGbCtD
Antipyrine—CYP2E1—Thalidomide—hematologic cancer	0.0093	0.0169	CbGbCtD
Antipyrine—CYP2C9—Bexarotene—hematologic cancer	0.00907	0.0165	CbGbCtD
Antipyrine—PTGS2—Betamethasone—hematologic cancer	0.00848	0.0154	CbGbCtD
Antipyrine—CYP2A6—Prednisolone—hematologic cancer	0.00827	0.015	CbGbCtD
Antipyrine—CYP2B6—Ifosfamide—hematologic cancer	0.00807	0.0147	CbGbCtD
Antipyrine—CYP2E1—Dacarbazine—hematologic cancer	0.00799	0.0145	CbGbCtD
Antipyrine—CYP2C8—Bortezomib—hematologic cancer	0.00797	0.0145	CbGbCtD
Antipyrine—CYP2D6—Lomustine—hematologic cancer	0.00771	0.014	CbGbCtD
Antipyrine—CYP1A2—Carmustine—hematologic cancer	0.00763	0.0139	CbGbCtD
Antipyrine—CYP2C9—Idarubicin—hematologic cancer	0.00752	0.0137	CbGbCtD
Antipyrine—CYP2B6—Nilotinib—hematologic cancer	0.00701	0.0127	CbGbCtD
Antipyrine—CYP2D6—Idarubicin—hematologic cancer	0.00687	0.0125	CbGbCtD
Antipyrine—CYP2C19—Bortezomib—hematologic cancer	0.00669	0.0122	CbGbCtD
Antipyrine—CYP1A2—Methoxsalen—hematologic cancer	0.00649	0.0118	CbGbCtD
Antipyrine—CYP2E1—Mitoxantrone—hematologic cancer	0.0062	0.0113	CbGbCtD
Antipyrine—CYP1A2—Bortezomib—hematologic cancer	0.00617	0.0112	CbGbCtD
Antipyrine—CYP2C8—Ifosfamide—hematologic cancer	0.00611	0.0111	CbGbCtD
Antipyrine—PTGS2—Cisplatin—hematologic cancer	0.0061	0.0111	CbGbCtD
Antipyrine—PTGS2—Etoposide—hematologic cancer	0.006	0.0109	CbGbCtD
Antipyrine—CYP1A2—Daunorubicin—hematologic cancer	0.0059	0.0107	CbGbCtD
Antipyrine—CYP2D6—Hydroxyurea—hematologic cancer	0.00585	0.0106	CbGbCtD
Antipyrine—CYP2C19—Thalidomide—hematologic cancer	0.00583	0.0106	CbGbCtD
Antipyrine—CYP1A2—Alitretinoin—hematologic cancer	0.00578	0.0105	CbGbCtD
Antipyrine—CYP2C9—Bortezomib—hematologic cancer	0.00556	0.0101	CbGbCtD
Antipyrine—CYP2C19—Teniposide—hematologic cancer	0.00556	0.0101	CbGbCtD
Antipyrine—CYP1A2—Thalidomide—hematologic cancer	0.00538	0.00977	CbGbCtD
Antipyrine—CYP2C8—Nilotinib—hematologic cancer	0.00531	0.00965	CbGbCtD
Antipyrine—CYP3A4—Bexarotene—hematologic cancer	0.00528	0.00959	CbGbCtD
Antipyrine—CYP2C19—Ifosfamide—hematologic cancer	0.00513	0.00932	CbGbCtD
Antipyrine—CYP2D6—Bortezomib—hematologic cancer	0.00508	0.00924	CbGbCtD
Antipyrine—PTGS1—Etoposide—hematologic cancer	0.00506	0.0092	CbGbCtD
Antipyrine—PTGS2—Dexamethasone—hematologic cancer	0.00493	0.00896	CbGbCtD
Antipyrine—CYP3A4—Busulfan—hematologic cancer	0.0049	0.00891	CbGbCtD
Antipyrine—CYP3A4—Lomustine—hematologic cancer	0.0049	0.00891	CbGbCtD
Antipyrine—CYP2C19—Imatinib—hematologic cancer	0.0049	0.0089	CbGbCtD
Antipyrine—CYP2A6—Dexamethasone—hematologic cancer	0.00487	0.00885	CbGbCtD
Antipyrine—CYP2C9—Thalidomide—hematologic cancer	0.00484	0.0088	CbGbCtD
Antipyrine—CYP2B6—Irinotecan—hematologic cancer	0.00482	0.00875	CbGbCtD
Antipyrine—CYP1A2—Dacarbazine—hematologic cancer	0.00462	0.0084	CbGbCtD
Antipyrine—CYP2C9—Teniposide—hematologic cancer	0.00462	0.0084	CbGbCtD
Antipyrine—CYP1A2—Imatinib—hematologic cancer	0.00452	0.00822	CbGbCtD
Antipyrine—CYP3A4—Thiotepa—hematologic cancer	0.00437	0.00794	CbGbCtD
Antipyrine—CYP2C9—Ifosfamide—hematologic cancer	0.00426	0.00775	CbGbCtD
Antipyrine—CYP2C9—Imatinib—hematologic cancer	0.00407	0.0074	CbGbCtD
Antipyrine—CYP2B6—Cisplatin—hematologic cancer	0.00393	0.00714	CbGbCtD
Antipyrine—CYP2E1—Etoposide—hematologic cancer	0.00391	0.00711	CbGbCtD
Antipyrine—CYP2D6—Imatinib—hematologic cancer	0.00373	0.00677	CbGbCtD
Antipyrine—CYP2C9—Nilotinib—hematologic cancer	0.0037	0.00673	CbGbCtD
Antipyrine—CYP1A2—Dasatinib—hematologic cancer	0.00363	0.0066	CbGbCtD
Antipyrine—CYP3A4—Methoxsalen—hematologic cancer	0.0034	0.00618	CbGbCtD
Antipyrine—CYP2D6—Nilotinib—hematologic cancer	0.00339	0.00615	CbGbCtD
Antipyrine—CYP2D6—Vinorelbine—hematologic cancer	0.00336	0.0061	CbGbCtD
Antipyrine—CYP3A4—Bortezomib—hematologic cancer	0.00323	0.00588	CbGbCtD
Antipyrine—CYP2C19—Prednisone—hematologic cancer	0.00323	0.00587	CbGbCtD
Antipyrine—CYP2E1—Dexamethasone—hematologic cancer	0.00322	0.00584	CbGbCtD
Antipyrine—CYP2B6—Dexamethasone—hematologic cancer	0.00317	0.00576	CbGbCtD
Antipyrine—PTGS2—ovarian follicle—hematologic cancer	0.00313	0.203	CbGeAlD
Antipyrine—CYP3A4—Daunorubicin—hematologic cancer	0.00309	0.00562	CbGbCtD
Antipyrine—SLC22A6—Methotrexate—hematologic cancer	0.00293	0.00533	CbGbCtD
Antipyrine—CYP2C8—Etoposide—hematologic cancer	0.00292	0.00531	CbGbCtD
Antipyrine—CYP3A4—Cytarabine—hematologic cancer	0.00273	0.00496	CbGbCtD
Antipyrine—CYP3A4—Teniposide—hematologic cancer	0.00269	0.00488	CbGbCtD
Antipyrine—CYP2B6—Doxorubicin—hematologic cancer	0.00263	0.00478	CbGbCtD
Antipyrine—CYP3A4—Ifosfamide—hematologic cancer	0.00248	0.00451	CbGbCtD
Antipyrine—CYP2C8—Dexamethasone—hematologic cancer	0.0024	0.00437	CbGbCtD
Antipyrine—CYP3A4—Imatinib—hematologic cancer	0.00237	0.0043	CbGbCtD
Antipyrine—CYP1A2—Etoposide—hematologic cancer	0.00226	0.00411	CbGbCtD
Antipyrine—CYP3A4—Ruxolitinib—hematologic cancer	0.00223	0.00405	CbGbCtD
Antipyrine—CYP3A4—Nilotinib—hematologic cancer	0.00215	0.00391	CbGbCtD
Antipyrine—CYP3A4—Vinorelbine—hematologic cancer	0.00213	0.00388	CbGbCtD
Antipyrine—CYP2C9—Cisplatin—hematologic cancer	0.00207	0.00377	CbGbCtD
Antipyrine—CYP2D6—Vinblastine—hematologic cancer	0.00207	0.00376	CbGbCtD
Antipyrine—CYP2C19—Dexamethasone—hematologic cancer	0.00202	0.00366	CbGbCtD
Antipyrine—CYP3A4—Triamcinolone—hematologic cancer	0.00195	0.00355	CbGbCtD
Antipyrine—CYP3A4—Dasatinib—hematologic cancer	0.0019	0.00346	CbGbCtD
Antipyrine—CYP3A4—Mitoxantrone—hematologic cancer	0.00188	0.00342	CbGbCtD
Antipyrine—CYP2C9—Dexamethasone—hematologic cancer	0.00168	0.00305	CbGbCtD
Antipyrine—CYP3A4—Betamethasone—hematologic cancer	0.00168	0.00304	CbGbCtD
Antipyrine—CYP3A4—Prednisolone—hematologic cancer	0.00165	0.003	CbGbCtD
Antipyrine—TRPA1—lung—hematologic cancer	0.00158	0.102	CbGeAlD
Antipyrine—CYP3A4—Prednisone—hematologic cancer	0.00156	0.00284	CbGbCtD
Antipyrine—CYP2D6—Dexamethasone—hematologic cancer	0.00153	0.00278	CbGbCtD
Antipyrine—CYP3A4—Irinotecan—hematologic cancer	0.00148	0.00269	CbGbCtD
Antipyrine—CYP3A4—Vinblastine—hematologic cancer	0.00132	0.00239	CbGbCtD
Antipyrine—CYP3A4—Vincristine—hematologic cancer	0.00129	0.00235	CbGbCtD
Antipyrine—CYP2D6—Doxorubicin—hematologic cancer	0.00127	0.00231	CbGbCtD
Antipyrine—CYP3A4—Etoposide—hematologic cancer	0.00119	0.00215	CbGbCtD
Antipyrine—CYP3A4—Dexamethasone—hematologic cancer	0.000974	0.00177	CbGbCtD
Antipyrine—CYP3A4—Doxorubicin—hematologic cancer	0.000808	0.00147	CbGbCtD
Antipyrine—CYP2C19—hematopoietic system—hematologic cancer	0.000559	0.0362	CbGeAlD
Antipyrine—CYP2A6—lung—hematologic cancer	0.000505	0.0327	CbGeAlD
Antipyrine—CYP2C8—hematopoietic system—hematologic cancer	0.000488	0.0316	CbGeAlD
Antipyrine—CYP1A2—hematopoietic system—hematologic cancer	0.000457	0.0296	CbGeAlD
Antipyrine—CYP2B6—hematopoietic system—hematologic cancer	0.000438	0.0283	CbGeAlD
Antipyrine—CYP2C9—hematopoietic system—hematologic cancer	0.000433	0.0281	CbGeAlD
Antipyrine—CYP2E1—hematopoietic system—hematologic cancer	0.000411	0.0266	CbGeAlD
Antipyrine—PTGS1—hematopoietic system—hematologic cancer	0.000396	0.0256	CbGeAlD
Antipyrine—PTGS2—hematopoietic system—hematologic cancer	0.000378	0.0245	CbGeAlD
Antipyrine—CYP2C19—blood—hematologic cancer	0.00037	0.024	CbGeAlD
Antipyrine—CYP2B6—gonad—hematologic cancer	0.000333	0.0216	CbGeAlD
Antipyrine—CYP3A4—hematopoietic system—hematologic cancer	0.00033	0.0214	CbGeAlD
Antipyrine—CYP2D6—hematopoietic system—hematologic cancer	0.000325	0.0211	CbGeAlD
Antipyrine—CYP2C8—blood—hematologic cancer	0.000323	0.0209	CbGeAlD
Antipyrine—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000308	0.209	CbGdCrCtD
Antipyrine—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000308	0.209	CbGdCrCtD
Antipyrine—CYP1A2—blood—hematologic cancer	0.000302	0.0196	CbGeAlD
Antipyrine—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000301	0.205	CbGdCrCtD
Antipyrine—CYP2B6—blood—hematologic cancer	0.00029	0.0188	CbGeAlD
Antipyrine—CYP2C9—blood—hematologic cancer	0.000287	0.0186	CbGeAlD
Antipyrine—CYP2E1—blood—hematologic cancer	0.000272	0.0176	CbGeAlD
Antipyrine—CYP2C8—testis—hematologic cancer	0.000267	0.0173	CbGeAlD
Antipyrine—CYP1A2—lung—hematologic cancer	0.000265	0.0172	CbGeAlD
Antipyrine—PTGS1—blood—hematologic cancer	0.000262	0.017	CbGeAlD
Antipyrine—CYP2B6—lung—hematologic cancer	0.000254	0.0165	CbGeAlD
Antipyrine—PTGS2—blood—hematologic cancer	0.000251	0.0162	CbGeAlD
Antipyrine—PTGS2—bone marrow—hematologic cancer	0.000242	0.0157	CbGeAlD
Antipyrine—CYP2B6—testis—hematologic cancer	0.00024	0.0155	CbGeAlD
Antipyrine—CYP2E1—lung—hematologic cancer	0.000239	0.0155	CbGeAlD
Antipyrine—PTGS1—lung—hematologic cancer	0.00023	0.0149	CbGeAlD
Antipyrine—CYP2E1—testis—hematologic cancer	0.000225	0.0146	CbGeAlD
Antipyrine—PTGS2—lung—hematologic cancer	0.00022	0.0142	CbGeAlD
Antipyrine—CYP3A4—blood—hematologic cancer	0.000219	0.0142	CbGeAlD
Antipyrine—PTGS1—testis—hematologic cancer	0.000217	0.014	CbGeAlD
Antipyrine—CYP2D6—blood—hematologic cancer	0.000215	0.014	CbGeAlD
Antipyrine—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000186	0.126	CbGdCrCtD
Antipyrine—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000186	0.126	CbGdCrCtD
Antipyrine—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000182	0.124	CbGdCrCtD
Antipyrine—CYP2D6—testis—hematologic cancer	0.000178	0.0115	CbGeAlD
Antipyrine—PTGS1—lymph node—hematologic cancer	0.000157	0.0102	CbGeAlD
Antipyrine—PTGS2—lymph node—hematologic cancer	0.00015	0.00973	CbGeAlD
Antipyrine—CYP1A2—Metabolism—NUP214—hematologic cancer	3.32e-06	6.3e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CA9—hematologic cancer	3.31e-06	6.29e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.31e-06	6.29e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.3e-06	6.26e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CD44—hematologic cancer	3.3e-06	6.26e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.28e-06	6.24e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.27e-06	6.22e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.27e-06	6.22e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.27e-06	6.2e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CG—hematologic cancer	3.25e-06	6.18e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—MTR—hematologic cancer	3.25e-06	6.17e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.25e-06	6.17e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.23e-06	6.13e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—EP300—hematologic cancer	3.19e-06	6.06e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.19e-06	6.06e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.19e-06	6.05e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—BAD—hematologic cancer	3.18e-06	6.05e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—NOTCH1—hematologic cancer	3.15e-06	5.99e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.12e-06	5.94e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.12e-06	5.93e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.11e-06	5.91e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.1e-06	5.89e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.09e-06	5.87e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD80—hematologic cancer	3.09e-06	5.87e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—KIT—hematologic cancer	3.08e-06	5.86e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.08e-06	5.85e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.08e-06	5.85e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.08e-06	5.84e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.08e-06	5.84e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TXN—hematologic cancer	3.08e-06	5.84e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—MTHFR—hematologic cancer	3.07e-06	5.84e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.04e-06	5.78e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CD44—hematologic cancer	3.03e-06	5.76e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.03e-06	5.76e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PTPN11—hematologic cancer	3.03e-06	5.76e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.02e-06	5.74e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CREBBP—hematologic cancer	3.02e-06	5.73e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.01e-06	5.72e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CD44—hematologic cancer	3.01e-06	5.71e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.01e-06	5.71e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.98e-06	5.66e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.95e-06	5.61e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.94e-06	5.59e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CREB1—hematologic cancer	2.94e-06	5.58e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.92e-06	5.54e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—BRAF—hematologic cancer	2.9e-06	5.51e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—MTHFR—hematologic cancer	2.89e-06	5.5e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.89e-06	5.49e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.89e-06	5.48e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.87e-06	5.45e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IL6R—hematologic cancer	2.86e-06	5.44e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CD—hematologic cancer	2.86e-06	5.43e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CREBBP—hematologic cancer	2.86e-06	5.43e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CREBBP—hematologic cancer	2.85e-06	5.42e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.85e-06	5.42e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.85e-06	5.41e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYCS—hematologic cancer	2.84e-06	5.4e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.83e-06	5.38e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.83e-06	5.38e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.83e-06	5.37e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ALB—hematologic cancer	2.82e-06	5.36e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.81e-06	5.34e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.81e-06	5.34e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.79e-06	5.3e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.75e-06	5.22e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.74e-06	5.21e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MAP2K1—hematologic cancer	2.73e-06	5.19e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.72e-06	5.18e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CD—hematologic cancer	2.71e-06	5.15e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.71e-06	5.15e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	2.7e-06	5.14e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3R1—hematologic cancer	2.7e-06	5.13e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ALB—hematologic cancer	2.67e-06	5.07e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.66e-06	5.05e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.66e-06	5.04e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.6e-06	4.94e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—FGF2—hematologic cancer	2.6e-06	4.93e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CG—hematologic cancer	2.58e-06	4.91e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.58e-06	4.9e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.58e-06	4.9e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.57e-06	4.88e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CD44—hematologic cancer	2.57e-06	4.88e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3R1—hematologic cancer	2.56e-06	4.86e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.56e-06	4.86e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	2.55e-06	4.85e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.54e-06	4.83e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.53e-06	4.8e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.53e-06	4.8e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.53e-06	4.8e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.51e-06	4.78e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—MTR—hematologic cancer	2.51e-06	4.76e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.51e-06	4.76e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.51e-06	4.76e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.5e-06	4.75e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.49e-06	4.74e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—JAK2—hematologic cancer	2.49e-06	4.73e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.48e-06	4.72e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.46e-06	4.67e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.43e-06	4.62e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.43e-06	4.62e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MDM2—hematologic cancer	2.43e-06	4.61e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.43e-06	4.61e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.41e-06	4.59e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CREBBP—hematologic cancer	2.39e-06	4.55e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.39e-06	4.55e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.38e-06	4.53e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.37e-06	4.51e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MTOR—hematologic cancer	2.36e-06	4.49e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CB—hematologic cancer	2.36e-06	4.49e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD4—hematologic cancer	2.36e-06	4.48e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PIK3CA—hematologic cancer	2.36e-06	4.48e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.36e-06	4.48e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.33e-06	4.43e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.32e-06	4.41e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.32e-06	4.41e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.3e-06	4.38e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.3e-06	4.38e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.3e-06	4.37e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.27e-06	4.31e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.25e-06	4.28e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ALB—hematologic cancer	2.24e-06	4.26e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.23e-06	4.24e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDKN1B—hematologic cancer	2.22e-06	4.21e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.2e-06	4.19e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.18e-06	4.15e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.17e-06	4.13e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTEN—hematologic cancer	2.15e-06	4.09e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ALB—hematologic cancer	2.15e-06	4.09e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.14e-06	4.07e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.14e-06	4.07e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.14e-06	4.06e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ALB—hematologic cancer	2.11e-06	4.01e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.1e-06	3.99e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.07e-06	3.94e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.06e-06	3.92e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—EP300—hematologic cancer	2.05e-06	3.9e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.05e-06	3.9e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDKN1A—hematologic cancer	2.05e-06	3.89e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PTEN—hematologic cancer	2.04e-06	3.88e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTEN—hematologic cancer	2.04e-06	3.87e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.04e-06	3.87e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.03e-06	3.85e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.02e-06	3.83e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CD44—hematologic cancer	1.98e-06	3.77e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.98e-06	3.77e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CB—hematologic cancer	1.98e-06	3.76e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.97e-06	3.74e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.97e-06	3.74e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.97e-06	3.74e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.95e-06	3.7e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EP300—hematologic cancer	1.95e-06	3.7e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—EP300—hematologic cancer	1.94e-06	3.69e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—AKT1—hematologic cancer	1.93e-06	3.66e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.9e-06	3.61e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SRC—hematologic cancer	1.89e-06	3.6e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.88e-06	3.56e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.88e-06	3.56e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.86e-06	3.54e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.86e-06	3.54e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.85e-06	3.51e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—STAT3—hematologic cancer	1.83e-06	3.47e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ALB—hematologic cancer	1.82e-06	3.47e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—NRAS—hematologic cancer	1.82e-06	3.46e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.79e-06	3.41e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MAPK3—hematologic cancer	1.74e-06	3.31e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.74e-06	3.31e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.74e-06	3.31e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.74e-06	3.3e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.73e-06	3.28e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.71e-06	3.25e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PTEN—hematologic cancer	1.71e-06	3.25e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MYC—hematologic cancer	1.7e-06	3.22e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TGFB1—hematologic cancer	1.69e-06	3.22e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.65e-06	3.14e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.65e-06	3.13e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.64e-06	3.12e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—EP300—hematologic cancer	1.63e-06	3.1e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ALB—hematologic cancer	1.63e-06	3.09e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.61e-06	3.06e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.61e-06	3.06e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.6e-06	3.04e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.59e-06	3.01e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—KRAS—hematologic cancer	1.57e-06	2.98e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—EP300—hematologic cancer	1.57e-06	2.98e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.56e-06	2.97e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.56e-06	2.96e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—EP300—hematologic cancer	1.54e-06	2.92e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.53e-06	2.91e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.52e-06	2.89e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.52e-06	2.89e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.52e-06	2.89e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.52e-06	2.88e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.5e-06	2.86e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ALB—hematologic cancer	1.5e-06	2.84e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ALB—hematologic cancer	1.48e-06	2.82e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.46e-06	2.78e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PIK3CA—hematologic cancer	1.44e-06	2.74e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.44e-06	2.73e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.44e-06	2.73e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.43e-06	2.72e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.42e-06	2.7e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.39e-06	2.64e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.36e-06	2.57e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.34e-06	2.55e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HRAS—hematologic cancer	1.33e-06	2.53e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—EP300—hematologic cancer	1.33e-06	2.52e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.32e-06	2.51e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.31e-06	2.49e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.28e-06	2.44e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IL6—hematologic cancer	1.28e-06	2.42e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ALB—hematologic cancer	1.27e-06	2.41e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.24e-06	2.36e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—AKT1—hematologic cancer	1.24e-06	2.36e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.21e-06	2.31e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.21e-06	2.29e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—EP300—hematologic cancer	1.18e-06	2.25e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—AKT1—hematologic cancer	1.18e-06	2.24e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—AKT1—hematologic cancer	1.17e-06	2.23e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.16e-06	2.2e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.14e-06	2.17e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.14e-06	2.16e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.13e-06	2.15e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.13e-06	2.14e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.12e-06	2.13e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—EP300—hematologic cancer	1.09e-06	2.07e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—EP300—hematologic cancer	1.08e-06	2.05e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.05e-06	1.99e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.92e-07	1.88e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—AKT1—hematologic cancer	9.86e-07	1.87e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.82e-07	1.87e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALB—hematologic cancer	9.79e-07	1.86e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTEN—hematologic cancer	9.68e-07	1.84e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—AKT1—hematologic cancer	9.47e-07	1.8e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.36e-07	1.78e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—AKT1—hematologic cancer	9.28e-07	1.76e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—EP300—hematologic cancer	9.23e-07	1.75e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.76e-07	1.66e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.64e-07	1.64e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.06e-07	1.53e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—AKT1—hematologic cancer	8.02e-07	1.52e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.99e-07	1.52e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTEN—hematologic cancer	7.47e-07	1.42e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.16e-07	1.36e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—EP300—hematologic cancer	7.12e-07	1.35e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.83e-07	1.3e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—AKT1—hematologic cancer	6.58e-07	1.25e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—AKT1—hematologic cancer	6.53e-07	1.24e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—AKT1—hematologic cancer	5.58e-07	1.06e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.27e-07	1e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.3e-07	8.18e-06	CbGpPWpGaD
